Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...
MedPage Today on MSN
GLP-1 drugs may benefit cancer patients with brain lesions
Retrospective study finds link between blockbuster drugs and longer survival ...
Lung cancer remains the leading cause of cancer death in the United States, responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patients ...
A new study is shining a light on a potential way to make treatments work better for one of the deadliest forms of cancer. Researchers at Ohio University have identified a protein that could be a ...
Research shows that cancer survivors can lower their risk of death with increased physical activity. Here's what Black cancer ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non–Muscle-Invasive Bladder Cancer Patients were randomly assigned to ...
Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...
Tatiana Andia knew Colombia would permit her a medically assisted death. She took her country with her on the journey to dying. Tatiana Andia, who was diagnosed in 2023 with terminal lung cancer, at ...
Patients use a variety of coping strategies after receiving a diagnosis of incurable cancer, but although some strategies may improve quality of life (QOL), others may have a detrimental effect, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results